News & Insight
TriApex will be attending SOT 63rd annual meeting in March, looking forward to seeing you there!
2024-03-04


We are delighted to inform you that we will be attending the 2024 SOT annual meeting in Salt Lake City, UTAH at Salt Palace Convention Center from March 10th - 14th. Stop by our booth (#1443) to meet our experts and discuss how we can accelerate your research with our ophthalmology innovation research system.

We also invite you to join our poster session. The detail of poster presentation is as follows:

Session Title:  "Safety Assessment: Non-pharmaceutical"

Poster Title: "Common non-clinical safety risks in repeat dose toxicity studies of GalNAc-siRNA"

Poster Board Number: P179  

Time: 3/11/2024, 11:45 am - 1:45 pm 


Session Title: "Stem Cell Biology and Toxicology"

Poster Title: "In vitro preclinical cardiotoxicity assessment using human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs)"

Poster Board Number: P446  

Time: 3/13/2024, 9:15 am - 11:15 am 


We look forward to seeing you at the event!You can click here to discover more about our ophthalmology service.

分享文章:
推荐新闻
TriApex Express | Innovative Research Exchange at ARVO 2024
2024-05-17
Join us at ARVO 2024 this May! Come and meet our experts.
We are delighted to inform you that we will be attending the ARVO 2024 annual meeting in Seattle, Washington at the Seattle Convention Center from May 5th - 9th. We invite you to stop by our booth (#5010) to meet our experts and discuss how we can accelerate your research with our ophthalmology innovation research system.
2024-04-26
TriApex will be attending SOT 63rd annual meeting in March, looking forward to seeing you there!
2024-03-04
The 10th National Toxicology Congress of CST (10th NTCCST) will be held on April in Zhuhai.
近日,中国毒理学会发布最新通知:中国毒理学会第十次全国毒理学大会定于2023年4月8-11日在广东省珠海国际会展中心正式举行,大会论文投稿时间截止至2023年3月10日。
2023-02-08
The 2nd China-Lingang Biomedical Innovation and Development Summit 2022 Frontier Drug Research and Development theme Forum was successfully concluded
2022年12月3-4日,第二届中国•临港生物医药创新发展峰会—2022年前沿药物研发主题论坛在中国(上海)自由贸易试验区临港新片区生命蓝湾圆满落幕。
2022-12-05
Lichuan Yang , CEO of KBI from TriApex, was invited to attend the ICNS 2022 Focus Forum and give a keynote speech
2022年11月3日-4日·中国上海,ICNS 2022 第二届中枢神经系统药物深度聚焦论坛成功举办。
2022-11-07
订阅我们的新闻,实时了解最新资讯,立即订阅